zithromax and ciclesonide

zithromax has been researched along with ciclesonide* in 2 studies

Other Studies

2 other study(ies) available for zithromax and ciclesonide

ArticleYear
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:1

    No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.

    Topics: Aged; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Liver; Male; Middle Aged; Pregnenediones; SARS-CoV-2; Tokyo

2021
A case of COVID-19 infection presenting with a seizure following severe brain edema.
    Seizure, 2020, Volume: 80

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Azithromycin; Betacoronavirus; Brain Edema; Brain Infarction; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Decompression, Surgical; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Intracranial Hemorrhages; Lung; Magnetic Resonance Imaging; Male; Nephrosis; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Pregnenediones; SARS-CoV-2; Seizures; Severity of Illness Index; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed

2020